Painful joints, tender tendons and morning stiffness can make everyday activities difficult with psoriatic arthritis. Could laser therapy, photobiomodulation or a biolamp help? We examine clinical findings, safety and questions that remain open. Click a question to scroll to its answer within this article.
Which questions will this article answer?
- How does psoriatic arthritis differ from skin psoriasis?
- What did the low-level laser study involving 117 patients show?
- Can polarized light or a biolamp help affected hands?
- Are there studies of laser blood irradiation for psoriatic arthritis?
- Does less pain also mean controlled inflammation and protected joints?
- What do we know about morning stiffness, tendons and their attachments?
- How deeply does light penetrate, and can it influence joint inflammation?
- How do lasers, LEDs, biolamps and UV phototherapy differ?
- Is local joint illumination the same as ILIB or nasal application?
- Can light complement methotrexate, biologics and physiotherapy?
- What are the risks, and when should I seek medical assessment?
- How often should light be used, and how can benefit be assessed?
Full menu of the light research series — expand
How does psoriatic arthritis differ from skin psoriasis?
Psoriatic arthritis is an inflammatory disease affecting joints and tendon or ligament attachments. It can also involve the spine. It is associated with an improperly regulated immune response, rather than simply joint wear or a skin rash.
Look out for swelling, stiffness after resting, heel pain, a swollen whole finger or toe, and nail changes. Joint symptoms can precede visible psoriasis. New or persistent symptoms warrant rheumatology assessment; early treatment helps protect joint function. [1]
What did the low-level laser study involving 117 patients show?
A 2026 conference abstract describes a randomized, double-blind comparison of 59 patients receiving laser and 58 receiving sham treatment. After 8 weeks, pain on a 100 mm scale fell by an average of 42 mm versus 15 mm. This is an encouraging finding for pain management. [3]
However, the abstract provides insufficient wavelength, dose and application-site information to reproduce treatment at home. A related abstract with the same authors, patient count and schedule also reports functional improvement. It appears to describe the same cohort; we do not count it as a second independent confirmation. [4]
Can polarized light or a biolamp help affected hands?
A 2026 study: 38 women, 6 weeks. Adding polarized light to exercise improved pain and grip more than exercise alone; no between-group fine-motor advantage emerged. [5]
The study used a specific Bioptron system. Its small sample and short follow-up call for larger independent studies. The finding cannot automatically be extended to every biolamp, deeper joints or the long-term disease course.
Are there studies of laser blood irradiation for psoriatic arthritis?
Yes, published work also examines supravenous application through the skin. Novikova and colleagues studied 92 patients with arthritis and metabolic syndrome. After 3 months, adding laser was associated with a greater reduction in tender and swollen joint counts than medication alone. [6]
Another study of 230 patients in 5 groups reported the most favorable result with combined medication, supravenous laser and UVB. The contribution of laser alone cannot be isolated from that combined result. [7]
Here we assess publicly available abstracts. They provide interesting clinical evidence, but detailed methods, blinding and long-term follow-up are needed for a dependable assessment. Metabolic syndrome also defines a particular study population.
Does less pain also mean controlled inflammation and protected joints?
Pain relief, low inflammatory activity and joint protection are distinct outcomes. Less pain can be valuable, but does not alone demonstrate that joint damage has stopped or lasting remission has been achieved. Remission means minimal or absent disease activity, rather than a guarantee of permanent cure.
A rheumatologist assesses symptoms alongside swelling, function and, where appropriate, laboratory or imaging findings. EULAR recommends treatment targeting remission or low disease activity with regular reassessment. [2] The light studies discussed here do not establish long-term protection against joint destruction. [3][5][6][7]
What do we know about morning stiffness, tendons and their attachments?
Morning stiffness and tender tendon attachments can be disease features. Enthesitis is inflammation where a tendon or ligament attaches to bone. Pain in a similar location can also have a mechanical cause, making assessment important. [1][2]
The clearest findings in the cited light studies concern pain, grip or affected joint counts. They do not provide a reliable universal estimate of how many minutes morning stiffness will shorten, or whether a particular inflamed attachment will heal. Further studies should measure these outcomes directly. [3][5][6]
How deeply does light penetrate, and can it influence joint inflammation?
Tissue absorbs and scatters light. Penetration depends on wavelength, tissue thickness and composition, and application geometry. An experiment using 660 nm red light demonstrates the importance of these conditions. [8]
The dose at the skin is not the dose inside the joint. Power ratings or claims of “deep penetration” therefore do not establish clinical benefit. PBM research investigates effects on cellular signaling and pain; benefit in psoriatic arthritis must be demonstrated for a specific clinical approach. A hand result cannot simply be transferred to the hip.
How do lasers, LEDs, biolamps and UV phototherapy differ?
- Low-level lasers and LEDs: different sources used in PBM; wavelength, dose and application site need comparison.
- Polarized biolamp: the cited study used polychromatic, non-coherent light, a different source from a laser. [5]
- UV phototherapy: uses ultraviolet radiation mainly for skin manifestations. It was a separate component of the combination study. [7]
- High-intensity laser: has different safety requirements; low-level PBM instructions cannot be transferred to it. [9]
These findings do not identify one “best color” for psoriatic arthritis or establish that lasers are generally superior to LEDs or polarized light.
Is local joint illumination the same as ILIB or nasal application?
No. Local application targets a particular area. ILIB delivers light through a fiber into a vein. Supravenous application passes through skin above a vessel, while nasal application passes through mucosa. The site, transmitted dose and risks differ.
Supravenous laser studies [6][7] do not demonstrate the same result for intranasal application. That remains a separate research question; lack of direct verification does not prove ineffectiveness. Assessment nevertheless requires a study of that particular route in people with psoriatic arthritis.
Can light complement methotrexate, biologics and physiotherapy?
If a light approach is considered, its role is within individually assessed complementary care. A rheumatologist manages disease-modifying medication, including methotrexate and biologics. Feeling better after an application is not an instruction to stop them. [2]
Bring the device name, instructions and medication list, including ointments, to a consultation. Check intended use, photosensitivity and skin condition. Appropriate exercise and physiotherapy remain important; adapt intensity to inflammatory activity and joint function. [10]
What are the risks, and when should I seek medical assessment?
Risk depends on the device and dose. Low-level use does not automatically guarantee eye safety; unsuitable power or exposure can also injure skin. Follow eye-protection requirements and the intended method of use. Stop if burning, pain or worsening skin symptoms occur. [9]
Discuss photosensitizing medication, damaged skin and other restrictions in the instructions beforehand. Do not delay assessment of new or increasing joint swelling while trying light at home. A painful red eye or deteriorating vision requires prompt eye assessment because inflammation may be responsible. [1]
How often should light be used, and how can benefit be assessed?
These studies cannot establish a universal home protocol for psoriatic arthritis. A session count without dose, area and device information is not a usable treatment instruction. Increasing time or power does not necessarily improve the result.
If a professional recommends complementary use, agree on a goal and review date beforehand. Record pain from 0 to 10, minutes of morning stiffness, one everyday activity, swelling and tolerability. Also note medication and exercise changes. A personal record supports assessment but cannot isolate light's effect from other influences.
Persistent inflammation requires reassessment of the clinical treatment plan, rather than indefinitely extending a home trial. [2][10]
Frequently asked questions – brief answers
How does psoriatic arthritis differ from skin psoriasis?
It involves inflammation of joints and tendon attachments, not just skin symptoms. Swelling, painful heels and morning stiffness warrant assessment.
What did the low-level laser study involving 117 patients show?
The abstract reports a larger pain reduction with laser than with sham treatment. Missing technical details limit practical transfer of the result.
Can polarized light or a biolamp help affected hands?
Hand research offers an encouraging signal for complementary use. A particular protocol's effect cannot be guaranteed for every biolamp.
Are there studies of laser blood irradiation for psoriatic arthritis?
Yes. Supravenous studies report favorable adjunctive-treatment findings. They do not by themselves establish efficacy for nasal applicators or every home device.
Does less pain also mean controlled inflammation and protected joints?
Not automatically. Less pain is beneficial, but joint protection and inflammatory activity need separate evaluation.
What do we know about morning stiffness, tendons and their attachments?
These are important symptoms. The cited results do not establish a dependable light effect for every tendon or for the duration of morning stiffness.
How deeply does light penetrate, and can it influence joint inflammation?
Penetration depends on tissue and device parameters. The dose reaching the skin alone does not determine the dose or effect inside a joint.
How do lasers, LEDs, biolamps and UV phototherapy differ?
These are different technologies. Results depend on the specific protocol; UV effects on skin do not prove red-light effects on joints.
Is local joint illumination the same as ILIB or nasal application?
No. Local, intravenous, supravenous and nasal application have different conditions. Results cannot automatically be transferred between them.
Can light complement methotrexate, biologics and physiotherapy?
Complementary use can be assessed individually with a rheumatologist. Light does not replace joint-protective medication or automatically allow dose reductions.
What are the risks, and when should I seek medical assessment?
Protect your eyes and follow the instructions. Stop for burning or worsening skin symptoms; a painful red eye or declining vision needs prompt assessment.
How often should light be used, and how can benefit be assessed?
Follow the specific instructions and professional advice. Monitor pain, stiffness, function and swelling, and review benefit and continuation at the agreed time.
Sources and supporting evidence
Sources are linked to the relevant paragraphs. Sources 3 and 4 are conference abstracts and appear to describe the same cohort; for sources 5 to 7 we assess available abstracts. Technologies and outcomes differ. Checked on 10 November 2026.
- NIAMS. Psoriatic Arthritis: symptoms, causes and risk factors (2024). Open source ↗
- Gossec et al. EULAR recommendations for psoriatic arthritis: 2023 update (2024). DOI: 10.1136/ard-2024-225531. Open source ↗
- Munteanu-Covila, Russu, Groppa. Low-level laser therapy for pain reduction in psoriatic arthritis (2026). DOI: 10.4081/ahr.2026.177. Open source ↗
- Munteanu-Covila, Russu, Groppa. Pain response and functional improvement under laser therapy in psoriatic arthritis (2026). DOI: 10.4081/ahr.2026.178. Open source ↗
- Fadel Abd El Rahman et al. Effect of Polarized Light Therapy on Psoriatic Hand Arthritis. Medical Journal of Cairo University 94 (2026): 639–645. Open source ↗
- Novikova et al. Psychoneurohormonal disorders and quality of life in psoriatic arthritis: laser therapy (2026). DOI: 10.33920/med-14-2603-09. Open source ↗
- Novikova et al. Complex treatment of psoriatic arthritis and metabolic syndrome (2026). DOI: 10.33920/med-14-2601-02. Open source ↗
- Hu et al. Penetration of red light (660 nm) through live and cadaveric tissues (2019). PMID: 30851081; DOI: 10.1002/jbio.201900010. Open source ↗
- FDA. Frequently Asked Questions About Lasers: eye and skin safety. Open source ↗
- American College of Rheumatology. Psoriatic Arthritis: treatment and living with PsA (2025). Open source ↗











